Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1,149.00
-25.00 (-2.13%)
Apr 29, 2026, 5:24 PM IDT
TLV:REKA Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -18.07 | 6.21 | -6.91 | -2.04 | 6.62 | Upgrade
|
| Depreciation & Amortization | 30.6 | 32.52 | 29.92 | 27.48 | 22.86 | Upgrade
|
| Other Amortization | 0.18 | 0.14 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.16 | -23.44 | 0.05 | -0 | -0.05 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -0.23 | 0.04 | -0.04 | -1.19 | Upgrade
|
| Loss (Gain) on Equity Investments | 0.1 | -0.01 | 0.22 | - | 0.13 | Upgrade
|
| Stock-Based Compensation | 0.04 | -0.14 | 0.19 | 0.4 | 0.45 | Upgrade
|
| Other Operating Activities | 2.06 | -3.53 | 0.2 | 5.31 | 0.21 | Upgrade
|
| Change in Accounts Receivable | 0.74 | -8.51 | 6.8 | -14.56 | -14.4 | Upgrade
|
| Change in Inventory | -8.53 | 14.12 | 2.91 | -2.59 | 13.19 | Upgrade
|
| Change in Accounts Payable | 0.26 | 5.98 | -2.19 | 26.81 | -3.83 | Upgrade
|
| Change in Income Taxes | 2.6 | 3.48 | -0.09 | -2.19 | -1.35 | Upgrade
|
| Change in Other Net Operating Assets | 3.14 | -0.05 | -2.77 | 0.42 | -1.47 | Upgrade
|
| Operating Cash Flow | 12.95 | 26.54 | 28.35 | 39 | 21.17 | Upgrade
|
| Operating Cash Flow Growth | -51.21% | -6.38% | -27.31% | 84.24% | 87.62% | Upgrade
|
| Capital Expenditures | -7.03 | -8.69 | -11.49 | -6.93 | -13.49 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.43 | 30 | 0.06 | 0.03 | 0.13 | Upgrade
|
| Cash Acquisitions | - | - | -9.79 | -6 | -25.34 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.14 | -0.01 | -0.32 | -0.55 | -0.51 | Upgrade
|
| Investment in Securities | 0.45 | 0.15 | 0.04 | - | 3.65 | Upgrade
|
| Other Investing Activities | - | -6.16 | - | - | -0.35 | Upgrade
|
| Investing Cash Flow | -6.29 | 15.29 | -21.5 | -13.45 | -35.9 | Upgrade
|
| Short-Term Debt Issued | - | 11.35 | 3 | - | - | Upgrade
|
| Long-Term Debt Issued | 22 | 3 | 38 | 10 | 40 | Upgrade
|
| Total Debt Issued | 22 | 14.35 | 41 | 10 | 40 | Upgrade
|
| Short-Term Debt Repaid | -4.96 | - | - | -0.01 | -4.99 | Upgrade
|
| Long-Term Debt Repaid | -24.24 | -66.73 | -35.74 | -24.35 | -37.78 | Upgrade
|
| Total Debt Repaid | -29.2 | -66.73 | -35.74 | -24.36 | -42.78 | Upgrade
|
| Net Debt Issued (Repaid) | -7.2 | -52.38 | 5.26 | -14.36 | -2.78 | Upgrade
|
| Common Dividends Paid | - | - | - | -10 | - | Upgrade
|
| Other Financing Activities | -2.17 | -1.76 | -13.05 | - | - | Upgrade
|
| Financing Cash Flow | -9.37 | -54.13 | -7.78 | -24.36 | -2.78 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.01 | 0.03 | 0.03 | 0.41 | -0.78 | Upgrade
|
| Net Cash Flow | -2.69 | -12.28 | -0.9 | 1.61 | -18.29 | Upgrade
|
| Free Cash Flow | 5.92 | 17.85 | 16.86 | 32.07 | 7.68 | Upgrade
|
| Free Cash Flow Growth | -66.82% | 5.86% | -47.42% | 317.44% | - | Upgrade
|
| Free Cash Flow Margin | 1.97% | 5.55% | 5.24% | 10.97% | 2.91% | Upgrade
|
| Free Cash Flow Per Share | 0.52 | 1.56 | 1.48 | 2.81 | 0.67 | Upgrade
|
| Cash Interest Paid | 6.25 | 7.25 | 8.55 | 5.69 | 5.74 | Upgrade
|
| Cash Income Tax Paid | 0.23 | 9.4 | 0.99 | 6.1 | 3.77 | Upgrade
|
| Levered Free Cash Flow | 6.59 | 37.27 | 12.23 | 33.25 | -0.51 | Upgrade
|
| Unlevered Free Cash Flow | 10.6 | 41.46 | 17.42 | 36.78 | 3.01 | Upgrade
|
| Change in Working Capital | -1.79 | 15.02 | 4.65 | 7.9 | -7.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.